Tag ~juno therapeutics

Tag descriptions coming soon to Wherrelz News!


Cell therapies are giving Seattle an edge in biotech driving three acquisitions in under a month

BristolMyers Squibbs 74B acquisition of Juno parent Celgene puts Seattle biotech world on alert

Week in Geek Podcast: A 9B biotech deal and a look at Pittsburghs tech renaissance

Seattlebased Shape Therapeutics raises 112M to develop RNAediting and gene therapies

Tech Moves: Hillel Cooperman named SVP at Oracle Seattle architecture leader Karen Thomas promoted at Gensler CrowdCow taps startup vet Fioca etc

Why Celgene decided to buy Juno Therapeutics for 9B with a little help from US tax reform

Juno Therapeutics acquired by Celgene for 9B in dramatic deal for rising biotech star

Celgene CEO: Treating cancer is becoming ironically easy now the problem is affordability

Tech moves: Groupon adds former Amazon VP as CTO Juno expands executive team and more

Tech Moves: Microsoft vets move to Amazon NurseGrid expands executive team and more

Longtime Juno Therapeutics CEO Hans Bishop leaves role after acquisition by Celgene

BristolMyers Squibb exec on how can Seattle grow and keep big biotech companies

Home run exits happen stealthily for biotech

Former Juno execs unveil Sana a new cell engineering biotech thats reportedly raising more than 800M

Juno Therapeutics agrees to pay 24M to stockholders in suit over disclosure of patient deaths

Longtime Juno Therapeutics CEO Hans Bishop leaves role after merger with Celgene

Led by former Juno execs Sana is a new cell engineering biotech thats reportedly raising more than 800M

Juno finds clinical success with cancer drug beats analyst expectations with 44M in revenue

Juno Therapeutics stock surges 50 as Celgene is reportedly in talks to buy the company